Is your microwave ablation technique up to date? Dr. Ed Kim sits down with guest-host Dr. Kavi Krishnasamy to explore cutting-edge techniques in tumor ablation, with a focus on hepatocellular carcinoma (HCC) treatment with microwave. Dr. Ed Kim is the Director of Interventional Oncology and Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at the Mount Sinai Medical Center.
---
This podcast is supported by an educational grant from Varian, a Siemens Healthineers company.
---
SYNPOSIS
The doctors discuss microwave ablation, radiation segmentectomy, and the decision-making algorithms for choosing appropriate procedures based on lesion characteristics. Dr. Kim touches on the complexities of ablation near the diaphragm and subcapsular lesions, emphasizing the impact of practitioner skill and experience on outcomes. Recent advancements in ablation technologies, software, and device-specific versus device-agnostic applications are also highlighted, along with the importance of post-contrast scans and ultrasound skills. Dr. Kim also delves into emerging technologies such as HistoSonics, augmented reality/virtual reality, and immunotherapy synergies. The doctors underscore the need for a multidisciplinary approach for optimizing patient outcomes and pushing the field toward future innovations.
---
TIMESTAMPS
00:00 - Introduction
04:28 - Standardizing Ablation Algorithms
07:51 - Suboptimal Lesion Locations
13:06 - Device Selection and Properties
22:49 - Ablation Planning Software
32:53 - Real-Time Visualization
44:48 - Biopsy and Ablation Techniques
52:14 - Future of Ablation Technology
---
RESOURCES
Dr. Ed Kim’s Publications:
https://scholars.mssm.edu/en/persons/edward-kim
ACCLAIM Trial:
https://www.sio-central.org/ACCLAIM-Trial
A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival:
https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.4093
Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial.
https://ascopubs.org/doi/10.1200/JCO.2024.42.17_suppl.LBA3501
SIR welcomes results of COLLISION Trial, presented at the 2024 ASCO Annual Meeting:
https://www.sirweb.org/media-and-pubs/media/news-release-archive/collision-trial-06032024/
HistoSonics:
https://histosonics.com/
